Search results
Pfizer (PFE) Up 1.8% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 6 days agoQ1 Earnings & Sales Top, EPS Guidance Raised Pfizer’s first-quarter results were strong as it beat...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
Reuters via AOL· 6 days agoPfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...
FDA Panel Recommends New COVID Vaccines For JN.1 Lineage By Fall
Forbes· 2 days agoA Food and Drug Administration expert panel voted Wednesday to manufacture new COVID-19 vaccines to...
AstraZeneca CEO Has No Plans to Retire as He Seeks to Nearly Double Sales by 2030
The Wall Street Journal· 6 days agoAstraZeneca’s longest-serving chief executive, Pascal Soriot, has no plans to step down for now as...
Pfizer (NYSE:PFE) Trading 0.3% Higher
ETF DAILY NEWS· 9 hours agoPfizer Inc. (NYSE:PFE – Get Free Report) traded up 0.3% during mid-day trading on Tuesday . The company traded as high as $29.73 and last traded at $29.41. 9,834,266 shares traded hands during ...
Why Things Could Get Worse for Pfizer Stock Before They Get Better | The Motley Fool
The Motley Fool· 1 day agoA few years ago, in the race to launch a COVID-19 vaccine, Pfizer (PFE 0.20%) stock was a hot buy...
Pfizer says its its lung cancer drug Lorbrena could be a $1 billion blockbuster
Quartz· 6 days agoAccording to the data, 61% of patients taking Lorbrena had no disease progression after five years,...
Is Pfizer the Best Dividend Stock for You?
Motley Fool via Yahoo Finance· 5 days agoThe falling share price has pushed the stock's dividend yield to nearly 6%. There are signs though that the reduced-performance pain may be nearing an...
A Dividend Stock Yielding Over 5% To Buy And Hold Forever
Benzinga via Yahoo Finance· 7 days agoInvesting in dividend stocks requires more than chasing high yields. Companies with attractive...
Is Pfizer the Best Dividend Stock for You? | The Motley Fool
The Motley Fool· 5 days agoThe pandemic-influenced revenue gusher from which pharmaceutical giant Pfizer (PFE 1.63%) benefitted...
